Clinical trials
Phase 2 Carcinoma trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 4 |
| 2010 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2023 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Unknown status | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| Pfizer | 2 |
| ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 1 |
| Association of Urologic Oncology (AUO) | 1 |
| AstraZeneca | 1 |
| Heidelberg University | 1 |
| Iovance Biotherapeutics, Inc. | 1 |
| Philogen S.p.A. | 1 |
| Replimune, Inc. | 1 |
| Revolution Medicines, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma | 17 |
| Lung Diseases | 4 |
| Adenocarcinoma | 3 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Carcinoma, Renal Cell | 3 |
| Lung Neoplasms | 3 |
| Bronchial Neoplasms | 2 |
| Neoplasms | 2 |
| Neuroendocrine Tumors | 2 |
| Basal Cell Carcinoma | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.